Home › Funds › Artia Global Partners LP › ROIV
Artia Global Partners LP position in ROIV
ROIVANT SCIENCES LTD · Health Care
Artia Global Partners LP reported holding 129,800 shares of ROIV (ROIVANT SCIENCES LTD) in its Q2 2026 13F filing — a position valued at US$4.6M, representing 0.85% of its reported portfolio and ranking #28 among its reported holdings. Artia Global Partners LP has disclosed ROIV holdings in 4 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Artia Global Partners LP's ROIV position evolved
Artia Global Partners LP first disclosed a stake in ROIV in Q3 2023 at 914,023 shares (US$10.7M). Across 4 filings, Artia Global Partners LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 129,800 shares valued at US$4.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 914.02K | $10.68M | New |
| Q4 2025 | 129.80K | $2.82M | New |
| Q1 2026 | 129.80K | $3.60M | Hold |
| Q2 2026 | 129.80K | $4.59M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ROIV and 13F data
ROIV (ROIVANT SCIENCES LTD) is a Health Care company. 64 other funds we track also report a position in ROIV — the largest reported positions include QVT Financial LP (US$839.6M), Farallon Capital Management (US$506.4M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$506.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ROIV
- QVT Financial LP 23.72M sh · $839.56M · Q2 2026
- Farallon Capital Management 14.31M sh · $506.40M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 14.31M sh · $506.40M · Q2 2026
- ADAGE CAPITAL PARTNERS GP, L.L.C. 10.35M sh · $366.26M · Q2 2026
- PERCEPTIVE ADVISORS LLC 8.09M sh · $286.14M · Q2 2026
- Patient Square Capital LP 8.02M sh · $283.86M · Q2 2026
- Darwin Global Management, Ltd. 6.75M sh · $234.33M · Q2 2026
- Rubric Capital Management LP 6.00M sh · $212.34M · Q2 2026
- BAKER BROS. ADVISORS LP 4.72M sh · $166.93M · Q2 2026
- Affinity Asset Advisors, LLC 3.75M sh · $132.71M · Q2 2026
- ADAR1 Capital Management, LLC 3.16M sh · $111.73M · Q2 2026
- Maverick Capital 2.83M sh · $100.12M · Q2 2026
More on Artia Global Partners LP
FAQ
How long has Artia Global Partners LP held ROIV?
Artia Global Partners LP has disclosed ROIV holdings in 4 of the last 12 reported quarters, going back to Q3 2023.
What is Artia Global Partners LP's current position in ROIV?
As of Q2 2026, Artia Global Partners LP holds 129.80K shares of ROIV (ROIVANT SCIENCES LTD), valued at $4.59M, representing 0.85% of its reported portfolio and ranking #28.
Has Artia Global Partners LP been buying or selling ROIV?
In the latest 13F filing (Q2 2026), Artia Global Partners LP held unchanged its position in ROIV.
Which other funds hold ROIV?
Other major institutional holders of ROIV include QVT Financial LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.